The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Login
EN
+7 (495) 482-4118
+7 (495) 482-4329
+8 800 250-18-12
  • (toll-free number for subscriptions)
    Mon-Fri from 10 a.m. to 6 p.m.

  • © 1998-2025
+7 (495) 482-43-29
EN
All journals
Journal
Year
Year
Search result: 0

Agafonov B.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Podrezova L.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Karavashkina E.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Vishniakova T.I.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Smirnova L.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Dadasheva M.N.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Shevtsova N.N.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Treatment of patients with movement and cognitive disorders in the residual period of stroke

Authors:

Agafonov B.V., Podrezova L.A., Karavashkina E.A., Vishniakova T.I., Smirnova L.A., Dadasheva M.N., Shevtsova N.N.

More about the authors

Journal: S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(12‑2): 55‑58

Read: 2379 times

Download PDF (RU)
Contact the author
Table of contents

TREATMENT OF PATIENTS WITH MOVEMENT AND COGNITIVE DISORDERS IN THE RESIDUAL PERIOD OF STROKE
TREATMENT OF PATIENTS WITH MOVEMENT AND COGNITIVE DISORDERS IN THE RESIDUAL PERIOD OF STROKE

To cite this article:

Agafonov BV, Podrezova LA, Karavashkina EA, Vishniakova TI, Smirnova LA, Dadasheva MN, Shevtsova NN. Treatment of patients with movement and cognitive disorders in the residual period of stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2010;110(12‑2):55‑58. (In Russ.)

Подписка 2026 Журнал неврологии и психиатрии им. С.С. Корсакова. Спецвыпуски (S.S. Korsakov Journal of Neurology and Psychiatry (special issues))
МСФ на ЯМ
Использование инфографики авторами научных работ
Close metadata
Recommended articles:
Clinical and epidemiological indi­cators of stroke during the COVID-19 pandemic and in the post-COVID period in the Moscow region. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):5-11
Connectome in stroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):46-50
Stroke: current state of the problem. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):7-18
Evaluation of the effe­ctiveness of the drug Cortexin in combination with the use of the application Apha­sia.No (Afaziyam.Net) in the correction of speech diso­rders in patients with cere­bral infa­rction. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(11):147-151
Differentiated approach to cognitive reha­bilitation of patients after stroke. Problems of Balneology, Physiotherapy and Exercise Therapy. 2024;(6):5-11
Cognitive impairment in bili­nguals with neurological diseases. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12):26-29
Fibrin mono­mer in diagnosis of cardiovascular diseases. Russian Cardiology Bulletin. 2024;(4-2):113-120
Analysis of risk factors asso­ciated with ischemic stroke in the setting of Ph-negative myeloproliferative diseases. Russian Journal of Preventive Medi­cine. 2025;(1):50-56
Cognitive vascular diso­rders and morphometric para­meters of the prefrontal, dorsolateral cortex and thalamus in post-stroke patients. S.S. Korsakov Journal of Neurology and Psychiatry. 2025;(2):91-95
Prevalence of cere­brovascular diseases risk factors acco­rding to the cohort survey data in Bishkek, Kyrgyz Repu­blic. Russian Journal of Preventive Medi­cine. 2025;(3):34-39
Abstract:

The efficacy and safety of axamon was studied in a trial with parallel groups in patients, aged 65-88 years, with movement and cognitive disorders in the residual period of stroke. Twenty-five patients received basic therapy and 25 patients were treated with axamon as an add-on drug in dosage of 20 mg 3 times a day during 12 weeks. Along with the neurological examination, a battery of neuropsychological scales and tests was used. The reduction of cognitive and movement deficits was observed. Axamon promotes the optimization of restoration potential of patients in the residual period of stroke.

Keywords:

stroke
axamon

Authors:

Agafonov B.V.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Podrezova L.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Karavashkina E.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Vishniakova T.I.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Smirnova L.A.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Dadasheva M.N.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Shevtsova N.N.

Moskovskiĭ oblastnoĭ nauchno-issledovatel'skiĭ klinicheskiĭ institut im. M.F. Vladimirskogo

Close metadata

References:

  1. Gusev E.I., Skvortsova V.I. Ishemiya golovnogo mozga. M 2001.
  2. Gusev E.I. Problema insul'ta v Rossii. Insul't 2003;9 (prilozhenie k Zhurnalu nevrologii i psikhiatrii).
  3. Putilina M.V. Khronicheskaya ishemiya mozga. Lechashchii vrach 2005;6:28-33.
  4. Gekht A.B. Ishemicheskii insul't: vtorichnaya profilaktika i osnovnye napravleniya farmakoterapii v vosstanovitel'nom periode. Consilium Medicum 2001;3:5.
  5. Damulin I.V., Parfenov V.A., Skoromets A.A., Yakhno N.N. Narusheniya krovoobrashcheniya v golovnom i spinnom mozge. V kn.: Bolezni nervnoi sistemy. Rukovodstvo dlya vrachei. M: Meditsina 2003;274-291.
  6. Damulin I.V. Distsirkulyatornaya entsefalopatiya: patogenez, klinika, lechenie. Metod. rekomendatsii. M 2005;48.
  7. Damaerschalck B.M., Winqerchuk D.M. Treatment of vascular dementia and vascular cognitive impairment. Neuroloqist 2007;13:1:37-41.
  8. Erkinjuntti T., Roman G., Gauthier S. et al. Emerging therapies for vascular dementia and vascular cognitive impairment. Stroke 2004;35:1010-1017.
  9. Gavrilova S.I. Farmakoterapiya bolezni Al'tsgeimera. M: Pul's 2003;109-115.
  10. Katunina E.A. Primenenie ipidakrina v vosstanovitel'nom periode ishemicheskogo insul'ta. Rus med zhurn 2008;16:12:1633.
  11. Allain H., Bentue-Firrer D., Belliard S. et al. Mild cognitive impairment: potentia therapeutics. Rev Neurol (Paris) 2002;158:10:35-40.
  12. Birks J. Cholinesterase inhibitors for Alzheimer’s disease. Cochrane Database Syst Rev 2006.
Contact the author
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

Contact us
If you have any questions, complaints or suggestions, please use this feedback form.
Email
Message
The publishing house "Media Sphere" does not provide treatment services, does not give recommendations on contacting medical institutions and specific specialists, on the prescription of medicines and dietary supplements.
Submit Application

You can become an author of one of our magazines, send a request and we will consider it in during the day.

Name
Phone
E-mail
Message
Login
Registration
E-mail
Password
Forgot Password?

Log in to the site using your account in one of the services

Password recovery
E-mail
Login
Register

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.